Word: doesn
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...slows down are during a couple of grisly, graphic moments involving rape and torture - scenes that are hard to endure, even if readers of the book know they're coming. The supporting characters are less memorable on screen than on the page; Taube's Henrik in particular sadly doesn't make much of an impression, while Lena Endre is an outright weak choice to play Blomkvist's editor Erika Berger. But if Dragon Tattoo gives short shrift to some of its players, it excels at giving us a sense of place, whether it's the frigid coastal setting of Sweden...
...suicide was what turned me around," says O'Barry. "The [animal entertainment] industry doesn't want people to think dolphins are capable of suicide, but these are self-aware creatures with a brain larger than a human brain. If life becomes so unbearable, they just don't take the next breath. It's suicide." (See the top 10 animal stories...
...Wilson's study provides that account of animal suicide and many others - that of a canvasback duck, a cat, pelicans, scorpions - but intentionally doesn't address the issue of whether these animals or any others are technically capable of ending their own lives. Thomas Joiner, a Florida State University psychologist, does take that stand. His new book, Myths About Suicide, links the suicidal tendencies of living creatures. "Across nature there seems to be the same kind of calculation," says Joiner. "Is my death worth more than my life? Suicides of all kinds involve this calculation, from bacteria and insects...
...cautious and asset-impaired or because businesses are uncertain about the future - or just aren't creditworthy borrowers? A recent survey by the National Federation of Independent Business found that companies that couldn't borrow typically had declining sales or depressed real estate values. Simply opening the lending spigot doesn't seem to be the answer...
...Close the Medicare Part D prescription drug gap known as the "donut hole," which leaves beneficiaries without prescription drug coverage once their costs exceed $2,830 (in 2010), and doesn't kick back in until they spend $4,550 out of pocket. This provision, which would cost the federal government about $20 billion over 10 years, gradually closes the gap beginning in 2011, so Medicare Part D recipients will eventually pay no more than 25% co-insurance for name-brand drugs. In 2010, Medicare Part D enrollees who reach the gap will receive $250 rebate checks...